NCT06804980 - DESIFOR-EXPAND (MHIF) | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Statin TherapyStatin Adverse ReactionStatin

Interventions

DRUG

Rosuvastatin (Crestor)

The patient will take 3 28-day packs of placebo and 2 28-day packs of rosuvastatin. The order in which they take the placebo or rosuvastatin will be assigned at random.

DRUG

Placebo

The patient will take 3 28-day packs of placebo and 2 28-day packs of rosuvastatin. The order in which they take the placebo or rosuvastatin will be assigned at random.

Trial Locations (1)

55407

RECRUITING

Minneapolis Heart Institute Foundation, Minneapolis

All Listed Sponsors

lead

Minneapolis Heart Institute Foundation

OTHER